share_log

UroGen Pharma Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(3.6%),Point72 Capital Advisors, Inc.(3.6%), etc.

烏龍製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-Point72 Asset Management, L.P.(3.6%),Point72 Capital Advisors, Inc.(3.6%)等

美股SEC公告 ·  11/15 08:52
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息